Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland
- PMID: 16720717
- DOI: 10.1677/jme.1.01991
Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland
Abstract
Androgen receptor (AR) is a ligand-activated transcription factor that mediates the action of androgens and is essential for the growth, function, and cell differentiation of the prostate gland. Here, we demonstrated that the prostate apoptosis response factor-4 (par-4) functions as a novel AR coactivator. Par-4 physically interacted with the DNA-binding domain of AR, enhanced AR interaction with DNA, and increased AR-dependent transcription. Par-4 enhanced the c-FLIP promoter activity and was recruited on to the c-FLIP gene in the presence of androgens, and the dominant-negative par-4 decreased c-FLIP expression. These results suggest that, in addition to its proapoptotic function, par-4 acts as a novel transcription cofactor for AR to target c-FLIP gene expression. In addition, we demonstrated that loss of c-FLIP expression was essential for castration-induced apoptosis in the prostate gland and that enhanced c-FLIP expression was associated with prostate cancer progression to the androgen-resistant stage. Our data shed light on a transcription-mediated mechanism for the effects of the AR pathway on cell survival and apoptosis.
Similar articles
-
FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells.Mol Cancer Res. 2008 Feb;6(2):231-42. doi: 10.1158/1541-7786.MCR-07-0386. Mol Cancer Res. 2008. PMID: 18314484
-
Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.Clin Cancer Res. 2007 Dec 1;13(23):7181-90. doi: 10.1158/1078-0432.CCR-07-1133. Clin Cancer Res. 2007. PMID: 18056199
-
Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.J Cell Biochem. 2008 Aug 15;104(6):2272-85. doi: 10.1002/jcb.21786. J Cell Biochem. 2008. PMID: 18481277
-
Mechanisms of prostate cancer cell survival after inhibition of AR expression.J Cell Biochem. 2009 Feb 15;106(3):363-71. doi: 10.1002/jcb.22022. J Cell Biochem. 2009. PMID: 19115258 Review.
-
Androgen receptor corepressors: an overview.Prostate. 2005 May 1;63(2):117-30. doi: 10.1002/pros.20170. Prostate. 2005. PMID: 15486994 Review.
Cited by
-
c-FLIP, a master anti-apoptotic regulator.Exp Oncol. 2012 Oct;34(3):176-84. Exp Oncol. 2012. PMID: 23070002 Free PMC article. Review.
-
c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.Biochem Pharmacol. 2008 Dec 15;76(12):1694-704. doi: 10.1016/j.bcp.2008.09.007. Epub 2008 Sep 17. Biochem Pharmacol. 2008. PMID: 18840411 Free PMC article.
-
Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.Curr Cancer Drug Targets. 2008 Feb;8(1):37-46. doi: 10.2174/156800908783497087. Curr Cancer Drug Targets. 2008. PMID: 18288942 Free PMC article. Review.
-
Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.Cancers (Basel). 2011 Jun;3(2):1639-71. doi: 10.3390/cancers3021639. Cancers (Basel). 2011. PMID: 22348197 Free PMC article.
-
4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells.Mol Cell Biochem. 2010 Sep;342(1-2):133-142. doi: 10.1007/s11010-010-0477-7. Epub 2010 May 6. Mol Cell Biochem. 2010. PMID: 20446019 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials